Abdulla A. Damluji, MD, PhD (@DrDamluji) / X

Abdulla A. Damluji, MD, PhD

19.3K posts

Abdulla A. Damluji, MD, PhD

@DrDamluji

Interventional Cardiologist | Clinical Professor of Medicine: #Aging | #Finance #Biotech @NYUStern | Threads on Trials in CV Medicine for Educational Purposes

Cleveland, OH

linkedin.com/in/drdamluji/

Joined May 2015

Pinned
Abdulla A. Damluji, MD, PhD
@DrDamluji
Aug 6, 2025
Establishing Cardiovascular Centers on Aging: The @ClevelandClinic Experience: @JACCJournals 🥸 Very excited to report our work on CV Centers on #Aging 😱 With enormous support from @tavrkapadia @venumenon10 @LarsSvenssonMD @CandiceSilvers1 jacc.org/doi/epdf/10.10… 👇👇
24K
Abdulla A. Damluji, MD, PhD
@DrDamluji
Aug 30, 2024
Beta-Blocker Interruption or Continuation after Myocardial Infarction: @NEJM 🥸Abyss trial is a very interesting name! 😱30 points summary! 👇👇👇
188K
Abdulla A. Damluji, MD, PhD
@DrDamluji
May 13, 2025
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity: @NEJM 🥸 SURMOUNT-5 Trial: Wow! 😱 Summary 👇👇👇
179K
Abdulla A. Damluji, MD, PhD
@DrDamluji
Aug 30, 2025
Beta-Blockers after Myocardial Infarction in Patients without Heart Failure: @NEJM @ESCCongress 🥸 Is evidence still in favor of beta blockers post AMI? #ESCCongress2025 😱Summary 👇👇👇
134K
Abdulla A. Damluji, MD, PhD
@DrDamluji
Nov 17, 2024
Routine Spironolactone in Acute Myocardial Infarction: @NEJM 🥸 Great trials from #AHA24: @ahasc 😱 Summary 👇👇👇
165K
Abdulla A. Damluji, MD, PhD
@DrDamluji
Mar 24, 2023
Right Ventricular Failure: @NEJM In-depth review on the right heart: @Brian_Houston12 @RyanTedfordMD Will try to hit the highlights, but cannot substitute for the details in the full text! 👇👇
149K
Abdulla A. Damluji, MD, PhD
@DrDamluji
Sep 10, 2025
Sepsis-induced cardiomyopathy: @ESC_Journals 🥸 Nicely done: please read full article - very useful. 😱 Here is the summary 👇👇👇
62K
Abdulla A. Damluji, MD, PhD
@DrDamluji
Aug 6, 2025
Acute coronary syndromes: mechanisms, challenges, and new opportunities: @ESC_Journals 🥸Very nice review - 😱Many research questions 👇👇👇
79K
Abdulla A. Damluji, MD, PhD
@DrDamluji
Oct 18, 2021
***IVUS Basics*** Tweetorial #cardiotwitter 1/ IVUS Guide Catheter
Abdulla A. Damluji, MD, PhD
@DrDamluji
Nov 17, 2024
Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity: @NEJM 🥸The SUMMIT trial - @AHAScience 😱 Summary 👇👇👇
118K
Abdulla A. Damluji, MD, PhD
@DrDamluji
Feb 3, 2025
The Physiology of Hunger: @NEJM 🥸 So this is not in CV medicine, but: (1) it is interesting and (2) it has implications for CV 😱 Good job @NEJM - Summary 👇👇👇
91K
Abdulla A. Damluji, MD, PhD
@DrDamluji
Jul 22, 2023
2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: @JACCJournals * I am reading this slowly: let's summarize in threads Read full document:🥸 Thread #1 👇👇👇
123K
Abdulla A. Damluji, MD, PhD
@DrDamluji
Jan 28, 2025
Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation: @NEJM 🥸Summary 👇👇👇
125K
Abdulla A. Damluji, MD, PhD
@DrDamluji
Aug 13, 2025
Aspirin, cardiovascular events, and major bleeding in older adults: extended follow-up of the ASPREE trial: @ESC_Journals 🥸Aspirin for primary prevention for older pts = MACE! 👇👇👇👇
125K